Background
Patients rushed to enroll almost as soon as word of the study got out. We were dealing with a significant unmet need: Most patients with Binge Eating Disorder (BED) seek help from psychiatrists, nutritionists, or obesity specialists. But there was no approved, effective pharmacologic treatment. And patients desperately wanted one.
Objective
With unanticipated interest in these pivotal Phase 3 studies, Premier Research needed to line up and train the right resources while collaborating effectively with the central laboratory, data manager, and other participants.
